Monte Rosa Therapeutics Inc

NASDAQ:GLUE   12:58:48 AM EDT
8.50
+0.02 (+0.24%)
Earnings Announcements

Monte Rosa Therapeutics Reports Third Quarter Results

Published: 11/10/2022 13:11 GMT
Monte Rosa Therapeutics Inc (GLUE) - Monte Rosa Therapeutics Reports Third Quarter 2022 Financial Results and Business Updates.
Monte Rosa Therapeutics - Expects Its Cash and Cash Equivalents Will Be Sufficient to Fund Planned Operations and Capital Expenditures Into Late 2024.
Monte Rosa Therapeutics Inc Qtrly Net Loss per Share Attributable to Common Stockholders-basic and Diluted $0.58.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.